跳至主要内容
临床试验/TCTR20230112003
TCTR20230112003尚未招募1 期

Clinical Study of Acupuncture Combined with Moxibustion in the treatment of Chemotherapy induced Peripheral Neuropathy

Weiyu Chang and Lijiang Ji0 个研究点目标入组 100 人开始时间: 2023年1月12日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • (1) Have received chemotherapy (complete at least one complete cycle), the primary disease condition is stable;
  • (2) Symptoms of chemotherapy-induced peripheral neuropathy after the end of chemotherapy;
  • (3) Age not less than18 years and not more than80 years;
  • (4) Karnofsky's performance status (KPS) score was greater than 60;
  • (5) Predicted survival time not less than 6 months;
  • (6) The patient has signed informed consent.

排除标准

  • (1) A history of neuropathy, such as diabetes, multiple sclerosis, HIV and Parkinson's disease;
  • (2) Patients with a variety of drug allergy or allergic constitution;
  • (3) Patients with other neurological diseases, which may affect the evaluation of efficacy;
  • (4) Patients with skin damage or infection at the acupoints that were not suitable for acupuncture or moxibustion;
  • (5) Patients suffering from mental illness.

研究者

发起方
Weiyu Chang and Lijiang Ji

相似试验

Clinical Study of Acupuncture Combined with... | 临床试验